SECTOR:

Oncology

FUND/VEHICLE:

NFLS Direct Investment

INVESTMENT DATE:

2018

GEOGRAPHY:

North America

STATUS CURRENT/FORMER INVESTMENT:

Existing

WEBSITE:

FogPharma is pioneering cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them.